Back | Next |
home / stock / ikt / ikt message board
Subject | By | Source | When |
---|---|---|---|
$IKT we got news | heyitsmeagain | investorshub | 04/22/2023 5:59:03 AM |
$IKT Long and strong lets hope im right | kzivann | investorshub | 04/22/2023 5:18:36 AM |
$IKT here we go bulls news is here | kzivann | investorshub | 04/22/2023 3:43:09 AM |
$IKT MomentumIts gaining up | conix | investorshub | 04/22/2023 2:50:01 AM |
The gaining up | ProfitScout | investorshub | 04/21/2023 11:42:55 PM |
$IKT MomentumIts trading | ProfitScout | investorshub | 04/21/2023 9:50:47 PM |
$IKT The trading | kzivann | investorshub | 04/21/2023 6:16:17 PM |
Do we have a winner?Turn around time? | ProfitScout | investorshub | 04/21/2023 9:45:49 AM |
Price now | conix | investorshub | 04/21/2023 7:51:15 AM |
$IKT The gaining | conix | investorshub | 04/21/2023 6:06:50 AM |
Price gaining | conix | investorshub | 04/21/2023 5:43:14 AM |
where is the squeeze? | heyitsmeagain | investorshub | 04/21/2023 3:11:24 AM |
The gaining | heyitsmeagain | investorshub | 04/20/2023 12:47:32 PM |
Have a look at this | conix | investorshub | 04/20/2023 11:33:01 AM |
$IKT what do you make of this data? | conix | investorshub | 04/20/2023 10:19:39 AM |
Price gaining | conix | investorshub | 04/20/2023 8:07:33 AM |
$IKT Thoughts on where this is headed? | conix | investorshub | 04/19/2023 11:41:59 PM |
Price now up | jedijazz | investorshub | 04/19/2023 10:41:18 PM |
$IKT Price trading | ProfitScout | investorshub | 04/19/2023 7:13:31 PM |
$IKT MomentumIts trading | conix | investorshub | 04/19/2023 2:44:58 PM |
News, Short Squeeze, Breakout and More Instantly...
Inhibikase Therapeutics Inc. Company Name:
IKT Stock Symbol:
NASDAQ Market:
BOSTON and ATLANTA, May 15, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinson...
- FDA indicated IkT-001Pro can be considered a New Molecular Entity and is eligible for exclusivity designations in Pulmonary Arterial Hypertension – BOSTON and ATLANTA, May 09, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or ...
Shares of Vaxxinity, Inc. (NASDAQ:VAXX) fell sharply during Monday's session after the company announced its intention to voluntarily delist a...